Cytoreductive surgery in multidisciplinary treatment of advanced hepatocellular carcinoma

ANZ Journal of Surgery

Volumn 78, Issue 6, 2008, Pages 504-507

  Lai, Eric C H ^a   Tang, Chung Ngai ^a   Ha, Joe P Y ^a   Tsui, David K K ^a   Li, Michael K W ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Cytoreductive surgery; Hepatectomy; Hepatocellular carcinoma; Radiofrequency ablation; Tumour debulking

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; LIVER CELL CARCINOMA; MALE; MORBIDITY; PALLIATIVE THERAPY; PARTIAL HEPATECTOMY; POSTOPERATIVE CARE; RADIOFREQUENCY ABLATION; SURGICAL MORTALITY; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 44649171743     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2008.04544.x     Document Type: Article

References (22)

1. Lau WY. Primary hepatocellular carcinoma. In : Blumgart LH, Fong Y eds). Surgery of the Liver and Biliary Tract. Volume II, 2nd edn. London : W.B. Saunders, 2000 1423 50.
2. Lau WY. Management of hepatocellular carcinoma. J. R. Coll. Surg. Edinb. 2002 47 : 389 99.
3. Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia. Surgeon. 2005 3 : 210 15.
4. Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann. Surg. 2003 237 : 171 9.
5. Lau WY, Yu SC, Lai EC, Leung TW. Transarterial chemoembolization for hepatocellular carcinoma. J. Am. Coll. Surg. 2006 202 : 155 68.
6. Lau WY, Leung TW, Leung KL et al. Cytoreductive surgery for hepatocellular carcinoma. Surg. Oncol. 1994 3 : 161 6.
7. Nagashima J, Okuda K, Tanaka M et al. Prognostic benefit in cytoreductive surgery for curatively unresectable hepatocellular carcinoma - comparison to transcatheter arterial chemoembolization. Int. J. Oncol. 1999 15 : 1117 23.
8. Liu CL, Fan ST, Lo CM et al. Hepatic resection for bilobar hepatocellular carcinoma: is it justified? Arch. Surg. 2003 138 : 100 104.
9. Wakabayashi H, Ushiyama T, Ishimura K et al. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. J. Surg. Oncol. 2003 82 : 98 103.
10. Pecorelli S, Odicino F, Favalli G. Ovarial cancer: best timing and applications of debulking surgery. Ann. Oncol. 2000 11 (Suppl 141 4.
11. Koppe MJ, Boerman OC, Oyen WJ et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann. Surg. 2006 243 : 212 22.
12. Shimamura Y, Gunven P, Ishii M et al. Debulking surgery and arterial embolization for unresectable liver cancer. Hepatogastroenterology. 1993 40 : 10 13.
13. Yamamoto M, Iizuka H, Matsuda M et al. The indications for tumor mass reduction surgery and subsequent multidisciplinary treatments in stage IV hepatocellular carcinoma. Surg. Today 1993 23 : 675 81.
14. Inoue K, Nakamura T, Kinoshita T et al. Volume reduction surgery for advanced hepatocellular carcinoma. J. Cancer. Res. Clin. Oncol. 2004 130 : 362 6.
15. Izumi R, Shimizu K, Miyazaki I. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma. Hepatogastroenterology. 1996 43 : 1415 20.
16. Ku Y, Iwasaki T, Tominaga M et al. Reductive surgery plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma. Ann. Surg. 2004 239 : 53 60.
17. Wong RJ, DeCosse JJ. Cytoreductive surgery. Surg. Gynecol. Obstet. 1990 170 : 276 81.
18. McCarter MD, Fong Y. Role for surgical cytoreduction in multimodality treatments for cancer. Ann. Surg. Oncol. 2001 8 : 38 43.
19. Taniai N, Yoshida H, Mamada Y et al. Is intraoperative adjuvant therapy effective for satellite lesions in patients undergoing reduction surgery for advanced hepatocellular carcinoma? Hepatogastroenterology. 2006 53 : 258 61.
20. Yamamoto K, Takenaka K, Kawahara N et al. Indications for palliative reduction surgery in advanced hepatocellular carcinoma. The use of a remnant tumor index. Arch. Surg. 1997 132 : 120 23.
21. Asahara T, Itamoto T, Katayama K et al. Indications for palliative reduction surgery for hepatocellular carcinoma with multiple intrahepatic metastases. Hiroshima. J. Med. Sci. 1998 47 : 115 20.
22. Lai EC, Lau WY. Cytoreductive (tumor-debulking) surgery. In : Lau WY (ed.). Hepatocellular Carcinoma. Singapore : World Scientific Publishing Co. Pte. Ltd., 2008 569 82.